Use of meloxicam (amelotex®) in patients with gonarthrosis
The paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug amelotex® (meloxicam) in patients with gonarthrosis. One-month meloxicam therapy is shown to have a good analgesic effect and tolerability and to improve quality of life in the patients.
Main Authors: | Maksim Sergeevich Eliseev, S A Vladimirov, Maksim Sergeyevich Eliseyev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2011-06-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/350 |
Similar Items
-
Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-09-01) -
USE OF INJECTABLE MELOXICAM (AMELOTEX®) FORMULATION IN PATIENTS WITH GONARTHROSIS
by: M S Eliseyev, et al.
Published: (2009-09-01) -
MELOXICAM: WHAT DO WE KNOW ABOUT CARDIOVASCULAR SAFETY?
by: M S Eliseev, et al.
Published: (2010-03-01) -
Meloxicam (movalis) in a physician's practice
by: Yuliya Leonidovna Korsakova, et al.
Published: (2011-09-01) -
The place and value of nonsteroidal anti-inflammatory drugs in the therapy of osteoarthritis
by: V. V. Badokin
Published: (2016-03-01)